IBDEI1N7 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27482,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,27482,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,27482,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,27483,0)
 ;;=N39.0^^132^1316^104
 ;;^UTILITY(U,$J,358.3,27483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27483,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,27483,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,27483,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,27484,0)
 ;;=N31.0^^132^1316^72
 ;;^UTILITY(U,$J,358.3,27484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27484,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,27484,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,27484,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,27485,0)
 ;;=R31.9^^132^1316^54
 ;;^UTILITY(U,$J,358.3,27485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27485,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,27485,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,27485,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,27486,0)
 ;;=R31.0^^132^1316^52
 ;;^UTILITY(U,$J,358.3,27486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27486,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,27486,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,27486,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,27487,0)
 ;;=R31.2^^132^1316^53
 ;;^UTILITY(U,$J,358.3,27487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27487,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,27487,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,27487,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,27488,0)
 ;;=R31.1^^132^1316^51
 ;;^UTILITY(U,$J,358.3,27488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27488,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,27488,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,27488,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,27489,0)
 ;;=N40.0^^132^1316^30
 ;;^UTILITY(U,$J,358.3,27489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27489,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,27489,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,27489,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,27490,0)
 ;;=N40.1^^132^1316^29
 ;;^UTILITY(U,$J,358.3,27490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27490,1,3,0)
 ;;=3^Enlarged Prostate w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,27490,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,27490,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,27491,0)
 ;;=N41.0^^132^1316^82
 ;;^UTILITY(U,$J,358.3,27491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27491,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,27491,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,27491,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,27492,0)
 ;;=N45.1^^132^1316^31
 ;;^UTILITY(U,$J,358.3,27492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27492,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,27492,1,4,0)
 ;;=4^N45.1
 ;;^UTILITY(U,$J,358.3,27492,2)
 ;;=^41396
 ;;^UTILITY(U,$J,358.3,27493,0)
 ;;=N45.2^^132^1316^74
 ;;^UTILITY(U,$J,358.3,27493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27493,1,3,0)
 ;;=3^Orchitis
 ;;^UTILITY(U,$J,358.3,27493,1,4,0)
 ;;=4^N45.2
 ;;^UTILITY(U,$J,358.3,27493,2)
 ;;=^86174
 ;;^UTILITY(U,$J,358.3,27494,0)
 ;;=N45.3^^132^1316^32
 ;;^UTILITY(U,$J,358.3,27494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27494,1,3,0)
 ;;=3^Epididymo-orchitis
 ;;^UTILITY(U,$J,358.3,27494,1,4,0)
 ;;=4^N45.3
 ;;^UTILITY(U,$J,358.3,27494,2)
 ;;=^5015707
 ;;^UTILITY(U,$J,358.3,27495,0)
 ;;=N47.2^^132^1316^76
 ;;^UTILITY(U,$J,358.3,27495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27495,1,3,0)
 ;;=3^Paraphimosis
 ;;^UTILITY(U,$J,358.3,27495,1,4,0)
 ;;=4^N47.2
